Diabetic macular edema (DME) is an eye condition that can lead to vision loss in people with diabetes. It occurs as a result of diabetic retinopathy — damaged blood vessels in the eyes due to elevated ...
An oral HIV drug helped patients with center-involved diabetic macular edema achieve improvements in visual acuity, according ...
Regeneron's EYLEA HD injection 8 mg approved by FDA for the treatment of macular edema following RVO
The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...
The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...
Using automated spectral-domain optical coherence tomography, researchers found the presence of subretinal fluid (SRF) in individuals with diabetic macular edema (DME) is associated with lower ...
Feb. 6, 2025 — The FDA has approved a new implantable treatment for adults with diabetic macular edema (DME) after studies showed that it could help maintain vision with as few as two treatments per ...
The optic cup and macula of a 24-year-old female. Image is released to Wikimedia commons with patient consent. Imaged with a non-mydriatic fundus camera at Pacific University College of Optometry.
On the innovative side, there are ongoing trials for combining therapies—anti-VEGF plus steroids or laser—to get better and faster outcomes. AI-assisted retina exams are enabling doctors to detect DME ...
LONDON--(BUSINESS WIRE)--The global diabetic macular edema treatment market 2018-2022 is expected to post a CAGR of more than 1% during the forecast period, according to the latest market research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback